Article info
PDFPapers
Research ethics
Post-trial access to study medication: a Brazilian e-survey with major stakeholders in clinical research
- Correspondence to Dr Sonia M Dainesi, Medicina Preventiva, University of Sao Paulo, Av Dr Arnaldo 455, 2° andar, Sao Paulo, SP 05403-000, Brazil; sdainesi{at}gmail.com
Citation
Post-trial access to study medication: a Brazilian e-survey with major stakeholders in clinical research
Publication history
- Received July 15, 2011
- Revised February 20, 2012
- Accepted July 20, 2012
- First published August 21, 2012.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Ethics Committee or Community? examining the identity of Czech Ethics Committees in the period of transition
- Implementing post-trial access plans for HIV prevention research
- What empirical research has been undertaken on the ethics of clinical research in India? A systematic scoping review and narrative synthesis
- Education of ethics committee members: experiences from Croatia
- Preventing ethics conflicts and improving healthcare quality through system redesign
- Harmonisation of ethics committees' practice in 10 European countries
- Investigation of post-trial access views among study participants and stakeholders using photovoice and semistructured interviews
- The promise and pitfalls of social science research in an emergency: lessons from studying the Zika epidemic in Brazil, 2015–2016
- Post-trial access to implantable neural devices: an exploratory international survey
- Subjects’ views of obligations to ensure post-trial access to drugs, care and information: qualitative results from the Experiences of Participants in Clinical Trials (EPIC) study